Peutz-jeghers syndrome with synchronous adenocarcinoma arising from ileal polyps

Mohit Sharma1, Rachhpal Singh2, Anumeet Singh Grover3

  • 1Department of Surgery, Sri Guru Ramdass Institute of Medical Sciences and Research, 1843 New State Bank Colony, Race Course Road, Vallah, 143001 Amritsar, India.

Insights

Peutz-Jeghers syndrome, a rare inherited disorder, presents with characteristic pigmentation and gastrointestinal polyps. This case highlights a young male with Peutz-Jeghers syndrome who developed synchronous malignant small intestine polyps, a rare complication.

Area of Science:

  • Gastroenterology
  • Oncology
  • Genetics

Background:

  • Peutz-Jeghers syndrome (PJS) is an inherited autosomal disorder.
  • PJS is characterized by mucocutaneous pigmentation and gastrointestinal hamartomatous polyps.
  • Increased risk of gastrointestinal and non-gastrointestinal malignancies is associated with PJS.

Purpose of the Study:

  • To report a rare case of Peutz-Jeghers syndrome with synchronous malignant small intestine polyps.
  • To discuss the clinical presentation and management of such a rare complication.

Main Methods:

  • Case report of a 29-year-old male with Peutz-Jeghers syndrome.
  • Diagnostic imaging including CT scan.
  • Endoscopic evaluation and polyp biopsy.
  • Histopathological examination of resected polyps.

Main Results:

  • The patient presented with recurrent abdominal pain due to an obstructing ileal polyp.
  • CT scan and preoperative endoscopy revealed multiple small and large polyps in the ileum and jejunum.
  • Histopathology confirmed mucinous adenocarcinoma in two ileal polyps and hamartomatous polyps in other locations.
  • Synchronous malignant transformation in small intestinal polyps within the context of PJS was observed.

Conclusions:

  • Peutz-Jeghers syndrome carries a significant risk of malignant transformation in gastrointestinal polyps.
  • Synchronous malignant small intestinal polyps in PJS are exceedingly rare.
  • Early diagnosis and vigilant endoscopic surveillance are crucial for managing PJS patients.

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.6K
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.4K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
881
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.9K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K